Adverse clinical outcomes after dabigatran reversal with idarucizumab to facilitate acute stroke thrombolysis
Crossref DOI link: https://doi.org/10.1007/s00415-017-8410-6
Published Online: 2017-02-06
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ng, Felix C.
Bice, James
Rodda, Anne
Lee-Archer, Matthew
Crompton, Douglas E.
License valid from 2017-02-06